Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 20:10:1228703.
doi: 10.3389/fnut.2023.1228703. eCollection 2023.

Molecular pathways and nutrigenomic review of insulin resistance development in gestational diabetes mellitus

Affiliations
Review

Molecular pathways and nutrigenomic review of insulin resistance development in gestational diabetes mellitus

Patricia Guevara-Ramírez et al. Front Nutr. .

Abstract

Gestational diabetes mellitus is a condition marked by raised blood sugar levels and insulin resistance that usually occurs during the second or third trimester of pregnancy. According to the World Health Organization, hyperglycemia affects 16.9% of pregnancies worldwide. Dietary changes are the primarily alternative treatment for gestational diabetes mellitus. This paper aims to perform an exhaustive overview of the interaction between diet, gene expression, and the metabolic pathways related to insulin resistance. The intake of foods rich in carbohydrates can influence the gene expression of glycolysis, as well as foods rich in fat, can disrupt the beta-oxidation and ketogenesis pathways. Furthermore, vitamins and minerals are related to inflammatory processes regulated by the TLR4/NF-κB and one carbon metabolic pathways. We indicate that diet regulated gene expression of PPARα, NOS, CREB3L3, IRS, and CPT I, altering cellular physiological mechanisms and thus increasing or decreasing the risk of gestational diabetes. The alteration of gene expression can cause inflammation, inhibition of fatty acid transport, or on the contrary help in the modulation of ketogenesis, improve insulin sensitivity, attenuate the effects of glucotoxicity, and others. Therefore, it is critical to comprehend the metabolic changes of pregnant women with gestational diabetes mellitus, to determine nutrients that help in the prevention and treatment of insulin resistance and its long-term consequences.

Keywords: gestational diabetes mellitus; insulin resistance; metabolic pathways; nutrients; nutrigenomic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Pathways related to insulin resistance. (A,C) Glucose breaks down producing pyruvate, which serves to produce energy in the TCA. (B) Glucose biosynthesis occurs from oxaloacetate. (C–E) Carnitine carries fatty acids into the mitochondria to synthesize acetyl-CoA, which serves to generate energy in the TCA cycle or to form ketone bodies via ketogenesis. (F) TLR4 activation sets off a series of events that culminate in the activation of NF-B, which is responsible for the synthesis and release of proinflammatory cytokines, eventually leading to GDM. Upward arrows indicate an elevation, while downward arrows indicate a reduction. Different colors represent each cellular process. GLUT, Glucose Transporter; PC, Pyruvate carboxylase; PDH, Pyruvate dehydrogenase; PEP, Phosphoenolpyruvate; OAA, Oxaloacetate; LPS, lipopolysaccharide; TLR4, Toll-like receptor 4; IKK, IκB Kinase; NF-kB, Nuclear factor κB.
Figure 2
Figure 2
One-carbon metabolism. GLUT, Glucose Transporter; THF, Tetrahydrofolate; 5-10-MTHF, 5,10-methylenetetrahydrofolate; 5-MTHF, 5-methyltetrahydrofolate; MTHFR, methylenetetrahydrofolate reductase; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine.

Similar articles

Cited by

References

    1. American Diabetes Association . 14. Management of Diabetes in pregnancy: standards of medical Care in Diabetes-2020. Diab Care. (2020) 43:S183–92. doi: 10.2337/dc20-S014, PMID: - DOI - PubMed
    1. McMicking J, Lam AYR, Lim W, Tan APLK, Pasupathy PD. Epidemiology and classification of diabetes in pregnancy. In: The global library of Women’s medicine (2021). 1–17.
    1. Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, et al. . IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in pregnancy study Group’s criteria. Diabetes Res Clin Pract. (2022) 183:109050. doi: 10.1016/j.diabres.2021.109050, PMID: - DOI - PubMed
    1. Alfadhli EM. Gestational diabetes mellitus. Saudi Med J. (2015) 36:399. doi: 10.15537/smj.2015.4.10307, PMID: - DOI - PMC - PubMed
    1. Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, et al. . Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract. (2003) 62:131–7. doi: 10.1016/j.diabres.2003.07.004, PMID: - DOI - PubMed

LinkOut - more resources